Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism HTRA1 inhibitors(HtrA serine peptidase 1 inhibitors), HTRA2 inhibitors(Serine protease HTRA2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Discovery | DE | - | |
Dystrophy, Macular | Discovery | DE | - | |
Perioperative ischaemia | Discovery | DE | - | |
Perioperative ischaemia | Discovery | DE | - |